GlyPerA™ effectively shields airway epithelia from SARS-CoV-2 infection and inflammatory events

GlyPerA™ effectively shields airway epithelia from SARS-CoV-2 infection and inflammatory events

Abstract New SARS-CoV-2 variants of concern (VOCs) and waning immunity illustrate that quick and easy-to-use agents are needed to prevent infection. To protect from viral transmission and subsequent inflammatory reactions, we applied GlyperA™, a novel antimicrobial formulation that can be used as mo...

Full description

Bibliographic Details
Main Authors: Viktoria Zaderer, Stefanie Dichtl, Wilfried Posch, Ivane Abiatari, Günther K. Bonn, Thomas Jakschitz, Lukas A. Huber, Teymuras V. Kurzchalia, Doris Wilflingseder
Format: Article
Language:English
Published: BMC 2023-03-01
Series:Respiratory Research
Subjects:
SARS-CoV-2
Prophylaxis
Variants of concern
Antiviral
Transmission
Online Access:https://doi.org/10.1186/s12931-023-02397-3

Internet

https://doi.org/10.1186/s12931-023-02397-3

Similar Items